Acquiring Company
ClinActiv Holdings
Acquired Company
Crescita Therapeutics
Nottingham
LavalHealth CareBeautyManufacturingBiotechnologyHealth CareCosmeticsDescription
ClinActiv Holdings Inc. has entered into a definitive agreement to acquire Crescita Therapeutics Inc. in an all-cash transaction. The target purchase price is set at $0.80 per Share, reflecting a 74% premium to Crescita's recent trading price. This acquisition is expected to enhance ClinActiv's dermatology platform and support Crescita's growth. The arrangement has received favorable endorsements from key Crescita stakeholders.
Quick answer
ClinActiv Holdings is acquiring Crescita Therapeutics, announced March 16, 2026. ClinActiv Holdings is based in Nottingham, England, United Kingdom.
- How much did ClinActiv Holdings pay for Crescita Therapeutics?
- The deal value was not disclosed.
- What does ClinActiv Holdings do?
- ClinActiv Holdings Inc. is a company focused on creating a global dermatology platform.
- Where are ClinActiv Holdings and Crescita Therapeutics based?
- ClinActiv Holdings is based in Nottingham, England, United Kingdom. Crescita Therapeutics is based in Laval, Quebec, Canada.
Source: Fundz verified event record.
Other recent acquisitions in Beauty and Cosmetics
Deals where the buyer or target shares a sector with this one, within 45 days, from Fundz verified event records.
- Cosmax acquires 51% of Cheminova in Italy (February 23, 2026)
- Oury Medical acquires Céfiméca for growth strategy (April 6, 2026)
- Emcure Pharmaceuticals acquires Cutimed Inc. for CAD 5.05M (April 2, 2026)
- CORONA Remedies acquires Wokadine® brand from Dr. Reddy's (March 31, 2026)
- Embecta to acquire Owen Mumford Holdings Limited (March 19, 2026)
- Kopran Limited to merge with Kopran Laboratories Limited (February 27, 2026)
Who to call at ClinActiv Holdings, and when
When ClinActiv Holdings changes hands, the new owners review vendors, systems and leadership. That is when the door opens.
- An alert the day ClinActiv Holdings raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at ClinActiv Holdings, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at ClinActiv Holdings. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment ClinActiv Holdings makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Frequently asked
Who acquired Crescita Therapeutics?
Crescita Therapeutics was acquired by ClinActiv Holdings, based in Nottingham. The deal was reported on March 16, 2026. ClinActiv Holdings Inc. is a company focused on creating a global dermatology platform. They aim to enhance their offerings through collaboration and targeted acquisitions. ClinActiv Holdings is privately held and operates in Health Care.
When did ClinActiv Holdings acquire Crescita Therapeutics?
ClinActiv Holdings's acquisition of Crescita Therapeutics was reported on March 16, 2026. ClinActiv Holdings Inc. has entered into a definitive agreement to acquire Crescita Therapeutics Inc. in an all-cash transaction. The target purchase price is set at $0.80 per Share, reflecting a 74% premium to Crescita's recent trading price. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does Crescita Therapeutics do?
Crescita Therapeutics Inc. is a growth-oriented, innovation-driven Canadian commercial dermatology company with in-house R&D and manufacturing capabilities. It is privately held, operating in Manufacturing, and is based in Laval.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.